Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 8 records, 1 pages
Search For: Erythropoietin (EPO)
Global Erythropoietin (EPO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Erythropoietin (EPO) market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13750 million by 2030 with a CAGR of 5.6% during review period.
USD3480.00
Add To Cart
Global Erythropoietin (EPO) Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Medical Care
According to our (Global Info Research) latest study, the global Erythropoietin (EPO) Drugs market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13240 million by 2030 with a CAGR of 5.0% during review period.
USD3480.00
Add To Cart
Global Erythropoietin (EPO) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Medical Care
According to our (Global Info Research) latest study, the global Erythropoietin (EPO) Drugs market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13240 million by 2030 with a CAGR of 5.0% during review period.
USD3480.00
Add To Cart
Global Erythropoietin (EPO) Treatment Supply, Demand and Key Producers, 2024-2030
19 Apr 2024
Pharma & Healthcare
Erythropoietin (EPO) Treatment
Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia. After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, original biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients).
USD4480.00
Add To Cart
Global Erythropoietin (EPO) Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
19 Apr 2024
Pharma & Healthcare
Erythropoietin (EPO) Treatment
Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia. After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, original biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients).
USD3480.00
Add To Cart
Global Erythropoietin (EPO) Supply, Demand and Key Producers, 2023-2029
06 Feb 2023
Pharma & Healthcare
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
USD4480.00
Add To Cart
Global Erythropoietin (EPO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
07 Jan 2023
Pharma & Healthcare
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
USD3480.00
Add To Cart
Global Erythropoietin (EPO) Drugs Supply, Demand and Key Producers, 2023-2029
30 Jan 2023
Medical Care
This report studies the global Erythropoietin (EPO) Drugs production, demand, key manufacturers, and key regions.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Erythropoietin (EPO)
Total: 8 records, 1 pages
According to our (Global Info Research) latest study, the global Erythropoietin (EPO) market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13750 million by 2030 with a CAGR of 5.6% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Erythropoietin (EPO) Drugs market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13240 million by 2030 with a CAGR of 5.0% during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Erythropoietin (EPO) Drugs market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13240 million by 2030 with a CAGR of 5.0% during review period.
USD3480.00
Add To Cart
Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia. After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, original biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients).
USD4480.00
Add To Cart
Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia. After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, original biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients).
USD3480.00
Add To Cart
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
USD4480.00
Add To Cart
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
USD3480.00
Add To Cart
This report studies the global Erythropoietin (EPO) Drugs production, demand, key manufacturers, and key regions.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>